Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)
Titel:
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)
Auteur:
Washam, Jeffrey B. Hellkamp, Anne S. Lokhnygina, Yuliya Piccini, Jonathan P. Berkowitz, Scott D. Nessel, Christopher C. Becker, Richard C. Breithardt, Günter Fox, Keith A.A. Halperin, Jonathan L. Hankey, Graeme J. Mahaffey, Kenneth W. Singer, Daniel E. Patel, Manesh R.